TCOV
BIO icon

Trust Company of Vermont’s Bio-Rad Laboratories Class A BIO Stock Holding History

Trust Company of Vermont’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15
Closed -$7.18K – 835
2023
Q1 		$7.18K Hold
15
– – ﹤0.01% 745
2022
Q4 		$6.31K Hold
15
– – ﹤0.01% 754
2022
Q3 		$6K Hold
15
– – ﹤0.01% 801
2022
Q2 		$7K Buy
+15
New +$7.81K ﹤0.01% 736

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Trust Company of Vermont's BIO Position: Q2 2023 in Review

Trust Company of Vermont sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 15 shares — an estimated $7.18K sold.

Trust Company of Vermont first reported a position in BIO in Q2 2022 and held it in 4 quarters. The position peaked at $7.18K in Q1 2023. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Trust Company of Vermont reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Trust Company of Vermont sold 15 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $7.18K.
  • Trust Company of Vermont first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and held it in 4 quarters.
  • Trust Company of Vermont's Bio-Rad Laboratories Class A position peaked at $7.18K in Q1 2023.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Trust Company of Vermont's 13F filing for Q2 2023, filed 17 Jul 2023.